Cited by 357Pain Management and TreatmentMusculoskeletal pain and rehabilitationSpinal Cord Injury Research

Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial.

Mekhail, Nagy, Levy, Robert M, Deer, Timothy R, Kapural, Leonardo, Li, Sean, Amirdelfan, Kasra, Hunter, Corey W, Rosen, Steven M +26 more·2020·The Lancet Neurology

Abstract

Background Spinal cord stimulation has been an established treatment for chronic back and leg pain for more than 50 years; however, outcomes are variable and unpredictable, and objective evidence of the mechanism of action is needed. A novel spinal cord stimulation system provides the first in vivo, real-time, continuous objective measure of spinal cord activation in response to therapy via recorded evoked compound action potentials (ECAPs) in patients during daily use. These ECAPs are also used to optimise programming and deliver closed-loop spinal cord stimulation by adjusting the stimulation current to maintain activation within patients' therapeutic window. We aimed to examine pain relief and the extent of spinal cord activation with ECAP-controlled closed-loop versus fixed-output, open-loop spinal cord stimulation for the treatment of chronic back and leg pain.Methods This multicentre, double-blind, parallel-arm, randomised controlled trial was done at 13 specialist clinics, academic centres, and hospitals in the USA. Patients with chronic, intractable pain of the back and legs (Visual Analog Scale [VAS] pain score ≥60 mm; Oswestry Disability Index [ODI] score 41-80) who were refractory to conservative therapy, on stable pain medications, had no previous experience with spinal cord stimulation, and were appropriate candidates for a spinal cord stimulation trial were screened. Eligible patients were randomly assigned (1:1) to receive ECAP-controlled closed-loop spinal cord stimulation (investigational group) or fixed-output, open-loop spinal cord stimulation (control group). The randomisation sequence was computer generated with permuted blocks of size 4 and 6 and stratified by site. Patients, investigators, and site staff were masked to the treatment assignment. The primary outcome was the proportion of patients with a reduction of 50% or more in overall back and leg pain with no increase in pain medications. Non-inferiority (δ=10%) followed by superiority were tested in the intention-to-treat population at 3 months (primary analysis) and 12 months (additional prespecified analysis) after the permanent implant. This study is registered with ClinicalTrials.gov, NCT02924129, and is ongoing.Findings Between Feb 21, 2017, and Feb 20, 2018, 134 patients were enrolled and randomly assigned (67 to each treatment group). The intention-to-treat analysis comprised 125 patients at 3 months (62 in the closed-loop group and 63 in the open-loop group) and 118 patients at 12 months (59 in the closed-loop group and 59 in the open-loop group). The primary outcome was achieved in a greater proportion of patients in the closed-loop group than in the open-loop group at 3 months (51 [82·3%] of 62 patients vs 38 [60·3%] of 63 patients; difference 21·9%, 95% CI 6·6-37·3; p=0·0052) and at 12 months (49 [83·1%] of 59 patients vs 36 [61·0%] of 59 patients; difference 22·0%, 6·3-37·7; p=0·0060). We observed no differences in safety profiles between the two groups. The most frequently reported study-related adverse events in both groups were lead migration (nine [7%] patients), implantable pulse generator pocket pain (five [4%]), and muscle spasm or cramp (three [2%]).Interpretation ECAP-controlled closed-loop stimulation provided significantly greater and more clinically meaningful pain relief up to 12 months than open-loop spinal cord stimulation. Greater spinal cord activation seen in the closed-loop group suggests a mechanistic explanation for the superior results, which aligns with the putative mechanism of action for spinal cord stimulation and warrants further investigation.Funding Saluda Medical.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(19)30414-4

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The electrical stimulation of the spinal cord for pain therapy can be adjusted based on the evoked compound action potential (ECAP).

    “Also, the electrical stimulation of the spinal cord for pain therapy can be adjusted based on the evoked compound action potential (ECAP) (Mekhail et al., 2020)”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mekhail, N., Levy, R. M., Deer, T. R., Kapural, L., Li, S., Amirdelfan, K., Hunter, C. W., Rosen, S. M., Costandi, S. J., Falowski, S. M., Burgher, A. H., Pope, J. E., Gilmore, C. A., Qureshi, F. A., Staats, P. S., Scowcroft, J., Carlson, J., Kim, C. K., Yang, M. I., Stauss, T., Poree, L., Brounstein, D., Gorman, R., Gmel, G. E., Hanson, E., Karantonis, D. M., Khurram, A., Kiefer, D., Leitner, A., Mugan, D., Obradovic, M., Parker, J., Single, P., & Soliday, N.
Affiliations
  • Cleveland Clinic (US)
  • Northwestern University (US)
  • The Spine & Nerve Centers of the Virginias (US)
  • Carolinas Pain Institute (US)
  • Ainsworth Institute of Pain Management (US)
  • Hope Research Institute (US)
  • Evolve Restorative Center (US)
  • Center for Clinical Research (United States) (US)
  • University of California, San Francisco (US)
Corresponding author
Mekhail, Nagy
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2020-02
Volume
19
Issue
2
Pages
123-134
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2994842882
Cited by
357
References
34
Citations by year
2026: 57 · 2025: 48 · 2024: 64 · 2023: 70 · 2022: 59 · 2021: 34 · 2020: 23 · 2019: 1 · 2012: 1
FWCI
41.67
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cleveland Clinic Foundation
  • Saluda Medical
  • Nevro
  • Biotronik
Topics
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
  • Health Sciences › Medicine › Pharmacology › Musculoskeletal pain and rehabilitation
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Spinal Cord Injury Research
Keywords
spinal cord stimulation, chronic back pain, leg pain, closed-loop stimulation, evoked compound action potential, non-inferiority, pain medication reduction, non-responders, long-term safety
MeSH terms
Adult, Aged, Back Pain, Double-Blind Method, Female, Humans, Leg, Male, Middle Aged, Pain Measurement, Spinal Cord, Treatment Outcome, Chronic Pain, Pain Management, Spinal Cord Stimulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review